Arcutis Biotherapeutics, Inc. ARQT Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s preferred stock, shares authorized?
- Arcutis Biotherapeutics, Inc. (ARQT) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s preferred stock, shares authorized changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s preferred stock, shares authorized?
- Over 4 years (2020 to 2024), Arcutis Biotherapeutics, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.